| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 84.14▼ | 84.27▼ | 84.10▲ | 85.60▼ | 83.87▲ |
| MA10 | 84.25▼ | 84.09▲ | 84.34▼ | 86.95▼ | 84.26▼ |
| MA20 | 84.27▼ | 84.42▼ | 84.85▼ | 84.07▲ | 82.52▲ |
| MA50 | 84.06▲ | 85.33▼ | 86.23▼ | 83.66▲ | 87.57▼ |
| MA100 | 84.31▼ | 86.48▼ | 85.53▼ | 82.03▲ | 103.73▼ |
| MA200 | 84.77▼ | 85.04▼ | 83.81▲ | 85.29▼ | 101.10▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.038▼ | 0.069▲ | 0.007▲ | -0.099▼ | 0.932▲ |
| RSI | 45.325▼ | 38.721▼ | 34.108▼ | 48.515▼ | 49.481▼ |
| STOCH | 16.896▼ | 61.524 | 25.301 | 37.093 | 52.213 |
| WILL %R | -72.000 | -62.857 | -74.634 | -51.783 | -48.047 |
| CCI | -124.313▼ | -5.219 | -59.548 | -35.068 | 45.977 |
|
Wednesday, October 15, 2025 10:16 AM
Welcome to The Pharma Letter’s real-time coverage of the 2025 European Society of Medical Oncology (ESMO) Congress, taking place October 17 to 21 in Berlin, Germany. This feed will deliver concise ...
|
|
Wednesday, October 15, 2025 09:23 AM
Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 studies with stable weight outcomes.
|
|
Wednesday, October 15, 2025 08:34 AM
Merck (NYSE:MRK) reported positive results from late-stage studies on a new oral treatment which combines two drugs, doravirine and islatravir, for adults with HIV-1. The studies looked at adults ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/10/25 | 84.19 | 84.69 | 83.61 | 84.11 | 9,168,705 |
| 14/10/25 | 85.38 | 85.68 | 84.15 | 84.70 | 9,675,036 |
| 13/10/25 | 85.655 | 86.46 | 85.24 | 85.70 | 6,553,942 |
| 10/10/25 | 87.935 | 88.24 | 85.92 | 85.99 | 11,230,694 |
| 09/10/25 | 86.96 | 87.80 | 86.64 | 87.50 | 10,938,196 |
| 08/10/25 | 87.93 | 87.93 | 86.20 | 86.40 | 9,696,200 |
| 07/10/25 | 88.67 | 88.94 | 87.14 | 87.61 | 9,449,085 |
| 06/10/25 | 88.83 | 90.31 | 88.55 | 88.80 | 11,648,298 |
| 03/10/25 | 89.625 | 90.70 | 88.10 | 89.19 | 12,970,576 |
| 02/10/25 | 89.95 | 91.00 | 88.22 | 89.51 | 14,575,377 |
|
|
||||
|
|
||||
|
|